Normal function · from ai-gene-review (Q96CV9, commit 79fe13b38970) · AI-generated, not KB evidence

Optineurin (OPTN) is a ubiquitously expressed, predominantly cytoplasmic coiled-coil adaptor protein that functions as a selective autophagy receptor. It carries two functional cargo-recognition modules: an LC3-interacting region (LIR motif, residues 176-181, with the critical Phe178) that binds ATG8-family modifiers (MAP1LC3A/B, GABARAP, GABARAPL1, GABARAPL2), and a UBAN (ubiquitin binding in ABIN and NEMO) motif (residues 474-479, with the essential Asp474/Phe475) that binds linear (M1) and K63-linked polyubiquitin chains. By simultaneously engaging ubiquitinated cargo and ATG8 proteins on the nascent autophagosomal membrane, OPTN bridges cargo to the autophagy machinery. Its C-terminus contains a CCHC NOA-type zinc finger (residues 547-577) that coordinates Zn2+. OPTN partners with and is activated by the kinase TBK1, which phosphorylates OPTN at Ser177 adjacent to the LIR, markedly increasing LC3 binding affinity and thereby driving cargo-selective autophagy. Through this mechanism OPTN mediates antibacterial xenophagy of ubiquitin-coated cytosolic bacteria (e.g. Salmonella) and PINK1/Parkin-dependent mitophagy of damaged mitochondria, acting alongside the related receptors SQSTM1/p62 and CALCOCO2/NDP52. As a NEMO-related protein, OPTN also regulates innate immune and inflammatory signaling: it negatively regulates canonical NF-kB signaling (competing for polyubiquitin within the TNFR1 complex) and dampens virus-triggered IFN-beta induction, while recruiting and activating TBK1 at the Golgi after RNA-virus sensing. Independently, OPTN links myosin VI and GTP-Rab8 to the Golgi complex, contributing to Golgi ribbon organization, post-Golgi exocytosis, and Rab8/TBC1D17-dependent endocytic recycling (e.g. of the transferrin receptor). OPTN mutations cause primary open-angle glaucoma (GLC1E; e.g. E50K), normal-pressure glaucoma, and amyotrophic lateral sclerosis with or without frontotemporal dementia (ALS12; e.g. the UBAN mutant E478G and the truncation Q398X), linking impaired selective autophagy and vesicular trafficking to neurodegeneration.

Acts as a selective autophagy receptor by simultaneously binding polyubiquitin chains on cargo (via the UBAN motif) and ATG8/LC3/GABARAP-family modifiers on the autophagosomal membrane (via the LIR motif), thereby bridging ubiquitinated cargo to the nascent autophagosome; TBK1-mediated phosphorylation at Ser177 enhances LC3 binding.
molecular function: protein-macromolecule adaptor activity · directly involved in: positive regulation of autophagy · locations: cytosol; autophagosome
Binds K63-linked and linear polyubiquitin chains via the UBAN domain, the molecular basis for recognizing ubiquitin-coated cargo (damaged mitochondria, cytosolic bacteria) and for engaging polyubiquitinated components of inflammatory/innate-immune signaling complexes.
Functions in antibacterial autophagy (xenophagy), serving as the cell-autonomous defense receptor that targets ubiquitin-coated cytosolic Gram-negative bacteria such as Salmonella for autophagic clearance, acting downstream of TBK1 and alongside SQSTM1/p62 and CALCOCO2/NDP52.
Serves as a receptor for PINK1/Parkin-dependent mitophagy, recognizing ubiquitinated outer-membrane proteins on depolarized/damaged mitochondria and recruiting LC3 to drive autophagosome formation around them; this function is disrupted by the ALS-linked UBAN mutant E478G.
molecular function: protein-macromolecule adaptor activity · directly involved in: type 2 mitophagy · locations: cytosol
In the knowledge base · computed from kb/ at build time

Disorders

Relationship is the entry's genetic[].relationship_type. untyped means the entry has a genetic record for the gene but does not type it; its free-text association is shown instead.

DisorderRelationshipWhere the gene appears
Amyotrophic Lateral Sclerosis causative
mechanism: Impaired Autophagy
subtype: ALS12
scoped to subtype: ALS12
OPTN-related Open Angle Glaucoma causativesusceptibility germline
Glaucoma untyped
Causative
ClinGen gene–disease validity · snapshot 2026-10-03 · matched to entries by MONDO

An entry matches when ClinGen's MONDO disease is the entry's own disease term, a subtype term, or an exact-match mapping. An amber status marks an entry ClinGen supports the gene for (Definitive, Strong or Moderate) whose own record does not type it. A Limited, Disputed or Refuted tier on such an entry is not a gap.

ClinGen diseaseMOIClassificationdismech entry
glaucoma, normal tension, susceptibility to MONDO:0011693 AD Definitive
2022-11-17
no dismech entry
amyotrophic lateral sclerosis type 12 MONDO:0013264 SD Definitive
2022-05-10
Mechanism modules · computed from kb/

Identity from HGNC (snapshot 2026-10-01). Page layers are described in the gene pages documentation.